title: Reply to ‘Evidence for harm, comment on . . .’ by  Kripke & Langer.
authors.forename: Anton
authors.initials: A
authors.lastname: Pottegård
authors.forename: Søren
authors.initials: S
authors.lastname: Friis
authors.forename: Morten
authors.initials: M
authors.lastname: Andersen
authors.forename: Jesper
authors.initials: J
authors.lastname: Hallas
mesh_terms: D001569:Benzodiazepines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D008297:Male; D009369:Neoplasms / Q000139:chemically induced*
chemical_list: D006993:Hypnotics and Sedatives; D001569:Benzodiazepines
references.citation: Am J Epidemiol. 2008 Feb 15;167(4):492-9
references.pmid: 18056625
references.citation: BMJ Open. 2012 Feb 27;2(1):e000850
references.pmid: 22371848
references.citation: Mayo Clin Proc. 2012 May;87(5):430-6
references.pmid: 22560522
references.citation: Acta Psychiatr Scand. 2000 Dec;102(6):429-31
references.pmid: 11142431
references.citation: Addict Behav. 2011 Jul;36(7):743-8
references.pmid: 21420792
references.citation: Br J Clin Pharmacol. 2014 Jul;78(1):186-7
references.pmid: 25083532
references.citation: Br J Clin Pharmacol. 2013 May;75(5):1356-64
references.pmid: 23043261
references.citation: Support Care Cancer. 2012 Jun;20(6):1203-10
references.pmid: 21637975
references.citation: BMJ. 2005 Nov 19;331(7526):1169
references.pmid: 16284208
references.citation: J Clin Psychiatry. 2012 Apr;73(4):e555-60
references.pmid: 22579162